Winfield Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-5
| Closed | -$1K | – | 140 |
|
|
2017
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 730 |
|
|
2017
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 658 |
|
|
2017
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 866 |
|
|
2017
Q1 | $0 | Sell |
5
-10
| -67% | – | ﹤0.01% | 748 |
|
|
2016
Q4 | $1K | Sell |
15
-5
| -25% | -$333 | ﹤0.01% | 600 |
|
|
2016
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 581 |
|
|
2016
Q2 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 576 |
|